muscle stiffness; Metallic taste; joint pain; itching; Flushing; Low grade fever; Headache; Mild swelling of eyes; Site soreness for 8 hours; Pain for 12 hours; Orbital itching+swelling for 14 hours; Rash+Redness (flushing) across upper chest+shoulders with itching+prickle sensation; Redness (flushing) across upper chest+shoulders with itching+prickle sensation; Rash+Redness (flushing) across upper chest+shoulders with itching+prickle sensation; Nausea for 12 hours post injection; Sneezing; Rhinorrhea; congestion with clear nasal drainage; mild unilateral Epistaxis x 2 episodes; Generalised urticaria; Generalised erythema; Generalised pruritis without skin rash; Red and itchy eyes; muscle cramps; muscle spasm; This is a spontaneous report received from a contactable reporter(s) (Pharmacist). The reporter is the patient.  A 39 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in deltoid left, administration date 12Oct2021 14:00 (Lot number: Ff8841) at the age of 39 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Htn" (unspecified if ongoing), notes: Htn; "Patients reports allergy to unknown red food dyes" (unspecified if ongoing), notes: Patients reports allergy to unknown red food dyes, Unknown red dye allergy (food dyes)-mild hives; "Food allergy" (unspecified if ongoing), notes: Unknown red dye allergy (food dyes)-mild hives; "Hives" (unspecified if ongoing), notes: Benadryl (Diphenhydramine) for hives+ itching due to red food dyes, Unknown red dye allergy (food dyes)-mild hives; "Itching" (unspecified if ongoing), notes: Benadryl (Diphenhydramine) for hives+ itching due to red food dyes. Concomitant medication(s) included: BENICAR; SYNTHROID; ASPIRIN 81; VIT C; VIT D [ERGOCALCIFEROL]; PROPANOLOL [PROPRANOLOL]. The following information was reported: MUSCULOSKELETAL STIFFNESS (non-serious) with onset 12Oct2021 20:00, outcome "recovering", described as "muscle stiffness"; DYSGEUSIA (non-serious) with onset 12Oct2021 20:00, outcome "recovering", described as "Metallic taste"; ARTHRALGIA (non-serious) with onset 12Oct2021 20:00, outcome "recovering", described as "joint pain"; PRURITUS (non-serious) with onset 12Oct2021 20:00, outcome "recovering", described as "itching"; FLUSHING (non-serious) with onset 12Oct2021, outcome "recovering", described as "Flushing"; PYREXIA (non-serious) with onset 12Oct2021, outcome "recovering", described as "Low grade fever"; HEADACHE (non-serious) with onset 12Oct2021, outcome "recovering", described as "Headache"; EYE SWELLING (non-serious) with onset 12Oct2021, outcome "recovering", described as "Mild swelling of eyes"; VACCINATION SITE PAIN (non-serious) with onset 12Oct2021, outcome "recovering", described as "Site soreness for 8 hours"; PAIN (non-serious) with onset 12Oct2021, outcome "recovering", described as "Pain for 12 hours"; EYE PRURITUS (non-serious) with onset 12Oct2021, outcome "recovering", described as "Orbital itching+swelling for 14 hours"; RASH (non-serious), PARAESTHESIA (non-serious) all with onset 12Oct2021, outcome "recovering" and all described as "Rash+Redness (flushing) across upper chest+shoulders with itching+prickle sensation"; ERYTHEMA (non-serious) with onset 12Oct2021, outcome "recovering", described as "Redness (flushing) across upper chest+shoulders with itching+prickle sensation"; NAUSEA (non-serious) with onset 12Oct2021, outcome "recovering", described as "Nausea for 12 hours post injection"; SNEEZING (non-serious) with onset 12Oct2021, outcome "recovering", described as "Sneezing"; RHINORRHOEA (non-serious) with onset 12Oct2021, outcome "recovering", described as "Rhinorrhea"; NASAL CONGESTION (non-serious) with onset 12Oct2021, outcome "recovering", described as "congestion with clear nasal drainage"; EPISTAXIS (non-serious) with onset 12Oct2021, outcome "recovering", described as "mild unilateral Epistaxis x 2 episodes"; URTICARIA (non-serious) with onset 12Oct2021, outcome "recovering", described as "Generalised urticaria"; ERYTHEMA (non-serious) with onset 12Oct2021, outcome "recovering", described as "Generalised erythema"; PRURITUS (non-serious) with onset 12Oct2021, outcome "recovering", described as "Generalised pruritis without skin rash"; OCULAR HYPERAEMIA (non-serious) with onset 12Oct2021, outcome "recovering", described as "Red and itchy eyes"; MUSCLE SPASMS (non-serious) with onset 12Oct2021, outcome "recovering", described as "muscle cramps"; MUSCLE SPASMS (non-serious) with onset 12Oct2021, outcome "recovering", described as "muscle spasm". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of musculoskeletal stiffness, dysgeusia, arthralgia, pruritus, flushing, pyrexia, headache, eye swelling, vaccination site pain, pain, eye pruritus, rash, erythema, paraesthesia, nausea, sneezing, rhinorrhoea, nasal congestion, epistaxis, urticaria, erythema, pruritus, ocular hyperaemia, muscle spasms, muscle spasms.  Additional information included: It was reported that patient was not diagnosed with COVID-19, prior to vaccination. Patient has not been tested COVID-19 since the vaccination. Patient describe the time course of the anaphylactic reaction: Metallic taste for 10 minutes post injection; site soreness for 8 hours;  joint stiffness+ pain for 12 hours; orbital itching+ swelling for 14 hours. Patient required antihistamine as medical intervention. Patient was treated with acetaminophen for fever and pain, ibuprofen for joint and moderate stiffness. Patient was not seen in emergency department. Patient was not hospitalised. Patient was not admitted to an intensive care unit. It was reported that dermatological/mucosal and other organs were also involved. Patient did not require the initiation of new medication or other treatment or procedure. Patient did not receive any recent vaccine for SARS-Cov2 other than Pfizer- BioNTech covid-19 vaccine prior to the event being reported.   No follow-up attempts are possible. No further information is expected.